Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans

Kristina Busygina, Janina Jamasbi, Till Seiler, Hans Deckmyn, Christian Weber, Richard Brandl, Reinhard Lorenz, Wolfgang Siess*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2605-2616
Number of pages12
JournalBlood
Volume131
Issue number24
DOIs
Publication statusPublished - 14 Jun 2018

Keywords

  • MULTIPLE ELECTRODE AGGREGOMETRY
  • PLATELET GLYCOPROTEIN-VI
  • SINGLE-AGENT IBRUTINIB
  • TERM-FOLLOW-UP
  • IN-VIVO
  • ACALABRUTINIB ACP-196
  • COMPLEMENTARY ROLES
  • CORONARY-ARTERIES
  • WHOLE-BLOOD
  • COLLAGEN

Cite this